×
Home Current Archive Editorial board
News Contact

Archive

More Filters

Contents

16.12.2024. Conference Presentations Biochemistry
The Next Generation of Telehealth

Tech is expensive, hospitals are closing and rural America is suffering. Access and workflow problems still exist, so how do we make this a workable success? Translating efficiencies do exist for consumer and health systems, but the elephant in the room is financial incentives and paying physicians for volume. Perhaps payors need to step up? Paneli...

By Shayan Vayas, MD, Greg Caressi, Sarah Bell, RN, MSN, MHA, Bill Fera, MD, Lyle Berkowitz, MD, Ritesh Patel, Moderator

03.04.2022. Video article Biochemistry
Health Tech Analyst Commentary & Market Watch

The panelists presents valuable market intelligence from leading experts including M&As, NewCos, SPACS, speculative bubbles, evaluating the consumer and provider experience, Big Tech failures and successes and future predictions. Why are public telehealth companies doing poorly and why are “niche” telehealth companies getting so muc...

By Berkowitz Lyle, Michael TS Lindenmayer, Peter Micca, Jailendra Singh

The  COVID-19 pandemic exponentially accelerated adoption of virtual care and heightened consumer expectations, which caused health systems to reimagine their role in virtual care. As a result, adoption of virtual care has empowered health systems to move beyond siloed applications to a comprehensive, whole-person approach that consumers ...

By Bruce Brandes, Lyle Berkowitz

Telehealth has received a lot of attention over the past few months as healthcare providers necessarily shifted. This was initiated by the need to decrease virus exposure and PPE usage, and then further enabled by pro-telehealth reimbursement and regulatory changes. What lessons were learned that help us envision what the future might look like ove...

By Lyle Berkowitz, Steve Ommen, John Halamka